EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Computer-Aided Drug Design Using the Fragment Molecular Orbital Method: Current Status and Future Applications for SBDD

Daisuke Takaya

Chemical and Pharmaceutical Bulletin · 01.09.2024 · 72 (9) · 781-786

DOI: 10.1248/cpb.c23-00839 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemical and Pharmaceutical Bulletin, erschienen am 01.09.2024. Verfasst von Daisuke Takaya. Beteiligte Einrichtung: Graduate School of Pharmaceutical Sciences, Osaka University. Hauptthemen laut MEDLINE: Drug Design, Computer-Aided Design, Quantum Theory. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DesignComputer-Aided DesignQuantum TheoryHumansLigandsMachine LearningMolecular Structure

Stichwörter der Autor:innen

computer-aided drug designfragment molecular orbital database (FMODB)fragment molecular orbital methodmachine learningstructure-based drug design

Substanzen

Ligands

Autor:innen und Institutionen

  • Graduate School of Pharmaceutical Sciences, Osaka University.

Zitieren

APA

Takaya, D. (2024). Computer-Aided Drug Design Using the Fragment Molecular Orbital Method: Current Status and Future Applications for SBDD. Chemical and Pharmaceutical Bulletin, 72(9), 781-786. https://doi.org/10.1248/cpb.c23-00839

Vancouver

Takaya D. Computer-Aided Drug Design Using the Fragment Molecular Orbital Method: Current Status and Future Applications for SBDD. Chemical and Pharmaceutical Bulletin. 2024;72(9):781-786. doi:10.1248/cpb.c23-00839

BibTeX
@article{Takaya2024,
  author = {Takaya, Daisuke},
  title = {Computer-Aided Drug Design Using the Fragment Molecular Orbital Method: Current Status and Future Applications for SBDD},
  journal = {Chemical and Pharmaceutical Bulletin},
  year = {2024},
  volume = {72},
  number = {9},
  pages = {781--786},
  doi = {10.1248/cpb.c23-00839}
}
Kostenlos starten →